arrow
B

Burkert Pieske

maastricht university medical centre (mumc)
H指数:114
被引数:8.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Health status and effects of spironolactone in people at high risk of heart failure: The Heart OMics in AGEing (HOMAGE) randomized trial

心力衰竭高风险人群的螺内酯健康状态及疗效:Heart OMics in AGEing(HOMAGE)随机试验

2026-05-010
OAAI
Catheter-based left atrial appendage CLOSURE in patients with Atrial Fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective randomized CLOSURE-AF trial

经导管左心耳闭合术在具有卒中及出血高风险的房颤患者中的应用,与最佳药物治疗比较:前瞻性随机CLOSURE-AF试验的方案与设计

2025-09-120
PRE
Effects of exercise training on motivation in patients with heart failure with preserved ejection fraction: Results from the randomized controlled Ex-DHF trial

运动训练对射血分数保留的心力衰竭患者动机的影响:来自随机对照Ex-DHF试验的结果

2025-08-060
PRE
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes

静脉用蔗糖铁在心力衰竭伴铁缺乏中的性别特异性结局(FAIR-HF2 DZHK05试验)

2025-07-310
OAAI
Geographic Variation and Human Development Index in Heart Failure With Reduced Ejection Fraction

地理变异与射血分数降低的心力衰竭中的人类发展指数

2025-07-110
OA
Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction

探讨代谢合并症对射血分数保留的心力衰竭患者心外膜脂肪组织的影响

2025-03-220
OA
Effects of exercise training on nitric oxide metabolites in heart failure with reduced or preserved ejection fraction: a secondary analysis of the SMARTEX-HF and OptimEx-Clin trials

运动训练对射血分数降低或保留的心力衰竭患者一氧化氮代谢物的影响:SMARTEX-HF和OptimEx-Clin试验的二次分析

2025-03-140
OAAI
Comparison of exercise training modalities and change in peak oxygen consumption in heart failure with preserved ejection fraction: a secondary analysis of the OptimEx-Clin trial
2024-10-250
PRE
Cardiac troponin elevation and mortality in takotsubo syndrome: New insights from the international takotsubo registry

takotsubo综合征的心肌肌钙蛋白升高和死亡率: 来自国际takotsubo登记处的新见解

2024-10-134
PRE
Biomarker profiles associated with reverse ventricular remodelling in patients with heart failure and a reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial

与心力衰竭和射血分数降低患者的逆向心室重塑相关的生物标志物谱: 来自VICTORIA试验的超声心动图子研究的见解

2024-07-301
OA
Catheter-based ablation to improve outcomes in patients with atrial fibrillation and heart failure with preserved ejection fraction: Rationale and design of the CABA-HFPEF-DZHK27 trial

基于导管的消融可改善射血分数保留的房颤和心力衰竭患者的预后: CABA-HFPEF-DZHK27试验的原理和设计

2024-07-181
OA
Cardiac biomarkers for diagnosing Takotsubo syndrome

诊断Takotsubo综合征的心脏生物标志物

2024-05-083
PRE
Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: A study of the ESC EORP PPCM registry

社会经济因素决定围产期心肌病妇女的母婴结局: ESC EORP PPCM注册研究

2024-03-016
OAAI
Noninvasive evaluation of pulmonary artery stiffness in heart failure patients via cardiovascular magnetic resonance

心血管磁共振无创性评价心力衰竭患者肺动脉僵硬度

2023-12-191
OAAI
Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort

当代心力衰竭队列中关键HFpEF/HFmrEF结果试验的非资格和死亡率

2023-12-013
OA
Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial
2023-11-083
OA